Obesity management in primary care: A joint clinical perspective and expert review from the Obesity Medicine Association (OMA) and the American College of Osteopathic Family Physicians (ACOFP) - 2025 [0.03%]
肥胖症的一线医疗管理：肥胖医学协会（OMA）和美国骨科家庭医生学院（ACOFP）的联合临床观点和专家综述-2025年版
Nicholas Pennings,Catherine Varney,Shaun Hines et al.
Nicholas Pennings et al.
Background: This collaboration from the Obesity Medicine Association (OMA) and the American College of Osteopathic Family Physicians (ACOFP) examines obesity management from a primary care perspective. ...
Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025 [0.03%]
肥胖儿童的代谢功能异常相关性脂肪肝病（MASLD）：肥胖医学协会（OMA）和专家联合观点（2025年版）
Jennifer Panganiban,Mohit Kehar,Samar H Ibrahim et al.
Jennifer Panganiban et al.
Introduction: This Obesity Medicine Association (OMA) Expert Joint Perspective examines steatotic liver disease (SLD), which is composed of metabolic dysfunction-associated steatotic liver disease (MASLD), and metabolic d...
Impact of metabolically healthy obesity on post percutaneous coronary intervention outcomes in patients with acute myocardial infarction: A nationwide propensity matched analysis [0.03%]
代谢健康型肥胖对急性心肌梗死患者经皮冠状动脉介入治疗术后预后的影响：全国范围内的倾向匹配分析
Rupak Desai,Adhvithi Pingili,Arankesh Mahadevan et al.
Rupak Desai et al.
Background: Obesity paradox in post-percutaneous coronary intervention (PCI) outcomes among acute myocardial infarction (AMI) patients is a known controversy. However, these studies included patients who had diabetes, hyp...
The association between hepatic steatosis, vitamin D status, and insulin resistance in adolescents with obesity [0.03%]
肥胖青少年肝脂肪变性、维生素D状态和胰岛素抵抗的相关性研究
Emir Tas,Amanda Flint,Ingrid Libman et al.
Emir Tas et al.
Introduction: Epidemiological studies suggest an inverse relationship between circulating 25-hydroxy-vitamin D [25(OH)D] levels and insulin resistance (IR), yet interventional studies have yielded inconsistent findings. T...
The effect of weight reduction on the diabetes foot: A scoping review and clinical implications [0.03%]
体重减轻对糖尿病足的影响：综述及临床意义
Janine E Roll Ahmed,John Veto,Derek Santos
Janine E Roll Ahmed
Background: This scoping review aims to explore the literature available on rapid weight reduction (either via diet/exercise or bariatric surgery) on the diabetes foot. ...
Harold Bays
Harold Bays
Appropriate use of the fixed-dose, extended-release combination of naltrexone and bupropion as treatment for obesity in primary care [0.03%]
初级保健中对纳曲酮和安非他酮固定剂量长效组合用于肥胖治疗的合适应用
Ethan Lazarus
Ethan Lazarus
Background: Obesity is considered a chronic disease and is influenced by biological, environmental, and behavioral factors that can contribute to its progression. Although lifestyle changes are integral to treating obesit...
Management and impact of obesity in Canada: A real-world survey of people with obesity and their physicians [0.03%]
加拿大肥胖症的管理及影响：一项关于肥胖人群及其医生的真实世界调查
Jennifer Glass,Sophie Carter,Esther Artime et al.
Jennifer Glass et al.
Background: Obesity is a chronic relapsing disease associated with multiple complications. This study described real-world demographic/clinical characteristics, including obesity-related complications (ORCs), prescribing ...
Prevalence and association of MASLD in metabolically healthy young Asian Americans with obesity: A nationwide inpatient perspective (2019) [0.03%]
代谢健康且肥胖的年轻亚裔美国人中MASLD的流行率及其关联性：全国住院患者视角（2019）
Ahmad Alhomaid,Sukhjinder Chauhan,Yamini Katamreddy et al.
Ahmad Alhomaid et al.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of chronic liver disease worldwide. Although the epidemiology of MASLD and its association with metabolically healthy obesity...
Cardiovascular safety of fixed-dose extended-release naltrexone/bupropion in clinical practice [0.03%]
临床实践中固定剂量的长效那可汀/安非他酮的心血管安全性
Michael Kyle,Dustin Burns,Catherine Rogers Murray et al.
Michael Kyle et al.
Background: The fixed-dose extended-release combination of naltrexone/bupropion (NB-ER) is indicated to treat overweight and obesity in adults as an adjunct to a reduced-calorie diet and increased physical activity. This ...